Editor's Choice
Reinvention starts here
BMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7422.0-g (Published 30 October 2003) Cite this as: BMJ 2003;327:0-gRelated articles
- Education And Debate Published: 30 October 2003; BMJ 327 doi:10.1136/bmj.327.7422.1041
- Editorial Published: 30 October 2003; BMJ 327 doi:10.1136/bmj.327.7422.1001
- Paper Published: 30 October 2003; BMJ 327 doi:10.1136/bmj.327.7422.1017
- Editorial Published: 30 October 2003; BMJ 327 doi:10.1136/bmj.327.7422.999
- News Published: 30 October 2003; BMJ 327 doi:10.1136/bmj.327.7422.1006-a
- News Published: 30 October 2003; BMJ 327 doi:10.1136/bmj.327.7422.1006-b
- News Published: 30 October 2003; BMJ 327 doi:10.1136/bmj.327.7422.1005-a
- News Published: 30 October 2003; BMJ 327 doi:10.1136/bmj.327.7422.1005
See more
- Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysisBMJ December 05, 2016, 355 i6188; DOI: https://doi.org/10.1136/bmj.i6188
- NHS to fund large trial of pre-exposure prophylaxis for HIV preventionBMJ December 05, 2016, 355 i6537; DOI: https://doi.org/10.1136/bmj.i6537
- Bill to boost medical research funding and speed drug approval passes US houseBMJ December 01, 2016, 355 i6498; DOI: https://doi.org/10.1136/bmj.i6498
- Alpha blockers for treatment of ureteric stones: systematic review and meta-analysisBMJ December 01, 2016, 355 i6112; DOI: https://doi.org/10.1136/bmj.i6112
- Sixty seconds on . . . solanezumabBMJ November 29, 2016, 355 i6389; DOI: https://doi.org/10.1136/bmj.i6389